Yoshida Ken, Yamazaki Hideya, Nose Takayuki, Shiomi Hiroya, Yoshida Mineo, Mikami Mari, Takenaka Tadashi, Kotsuma Tadayuki, Tanaka Eiichi, Kuriyama Keiko, Harada Yasunori, Tohda Akira, Yasunaga Yutaka, Oka Toshitsugu
Department of Radiology, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka City, Japan.
Brachytherapy. 2010 Jan-Mar;9(1):36-41. doi: 10.1016/j.brachy.2009.04.006. Epub 2009 Sep 6.
To introduce an effective ambulatory technique in high-dose-rate interstitial brachytherapy (HDR-ISBT) for prostate cancer, we investigated the displacement distance using our novel calculation method.
Sixty-four patients treated with HDR-ISBT as monotherapy were examined. Of these, 4, 17, and 43 patients were administered treatment doses of 38 Gy (3 days), 49 Gy (4 days), and 54 Gy (5 days), respectively. For dose administration, we used 776 flexible applicators with a removable template (ambulatory technique). Using CT images, we calculated the relative coordinates of the metal markers and applicators. From these coordinates, to analyze displacement during treatment, we measured the distance between the tip of the needle applicator and the center of gravity of the markers along the average applicator vector.
The median displacement distance for all applicators was 7 mm (range, -14 to 24), and that of each treatment schedule was 4, 6, and 9 mm for 38, 49, and 54 Gy, respectively. Of the 776 applicators, displacement of >10 mm was seen in 198 (26%) applicators and >15 mm in 57 (7%) applicators. Body height (p<0.0001) and anticoagulant usage (p<0.0001) were significant factors influencing displacement.
We investigated needle applicator displacement using our unique method. Additional cranial margins are necessary if there is no repositioning of the dwell position. CT scanning should be performed daily during treatment for checking the position of the applicator to detect and rectify the issue of displacement.
为了介绍一种用于前列腺癌高剂量率间质近距离放疗(HDR-ISBT)的有效门诊技术,我们使用我们新颖的计算方法研究了位移距离。
对64例接受HDR-ISBT单药治疗的患者进行了检查。其中,分别有4例、17例和43例患者接受了38 Gy(3天)、49 Gy(4天)和54 Gy(5天)的治疗剂量。对于剂量给药,我们使用了776个带有可移除模板的柔性施源器(门诊技术)。使用CT图像,我们计算了金属标记物和施源器的相对坐标。从这些坐标中,为了分析治疗期间的位移,我们沿着平均施源器向量测量了针状施源器尖端与标记物重心之间的距离。
所有施源器的中位位移距离为7 mm(范围为-14至24),每个治疗方案的位移距离分别为38 Gy时4 mm、49 Gy时6 mm和54 Gy时9 mm。在776个施源器中,198个(26%)施源器的位移大于10 mm,57个(7%)施源器的位移大于15 mm。身高(p<0.0001)和抗凝剂使用情况(p<0.0001)是影响位移的重要因素。
我们使用独特的方法研究了针状施源器的位移。如果驻留位置没有重新定位,则需要额外的颅侧边界。治疗期间应每天进行CT扫描以检查施源器的位置,以检测和纠正位移问题。